Becker's Healthcare January 10, 2025
Alan Condon

Walgreens Boots Alliance reported a $245 million operating loss in the first quarter of fiscal 2025, the three months ending Nov. 30, a substantial drop from the $39 million operating loss recorded in the same quarter in FY 2024.

“Our first quarter results reflect our disciplined execution against our 2025 priorities: stabilizing the retail pharmacy by optimizing our footprint, controlling operating costs, improving cash flow and continuing to address reimbursement models,” CEO Tim Wentworth said in a Jan. 10 news release. “While our turnaround will take time, our early progress reinforces our belief in a sustainable, retail pharmacy-led operating model.”

Eight things to know:

1. The increased losses were driven by higher costs from Walgreens’ footprint optimization program...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
Q&A: Nutritional Pharmacist's Perspective on New Year Dieting Trends
Walgreens CEO: ‘Turnaround Will Take Time’
What to expect in US healthcare in 2025 and beyond
Report: Prices for top Medicare Part D drugs nearly doubled since entering the market
Pharmacy benefit managers steer Medicare patients to use their own pharmacies

Share This Article